Lv31
214 积分 2024-01-30 加入
The coming of age of cyclic peptide drugs: an update on discovery technologies
1小时前
待确认
Property-Based Optimization of Cereblon-Based Molecular Glue Degraders
1个月前
已完结
Structural insight into selectivity of amylin and calcitonin receptor agonists
1个月前
已完结
A structural basis for amylin receptor phenotype
1个月前
已完结
Strategies and Lessons Learned from Total Synthesis of Taxol
2个月前
已完结
The changing landscape of medicinal chemistry optimization
2个月前
已完结
Cyclic Peptide Therapeutic Agents Discovery: Computational and Artificial Intelligence-Driven Strategies
3个月前
已完结
Structure-Based Drug Design and Synthesis of Pyrrolidine-2,5-diones as Novel TNF-α Inhibitors
6个月前
已完结
Structure-Based Design and Optimization of Methionine Adenosyltransferase 2A (MAT2A) Inhibitors with High Selectivity, Brain Penetration, and In Vivo Efficacy
7个月前
已完结
Discovery of Novel Spirocyclic MAT2A Inhibitors Demonstrating High In Vivo Efficacy in MTAP-Null Xenograft Models
7个月前
已完结
皖公网安备34019202002308
